We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$9.41B
AUM Growth
+$1.07B
Cap. Flow
+$1.36B
Cap. Flow %
14.49%
Top 10 Hldgs %
22.53%
Holding
1,822
New
181
Increased
1,122
Reduced
417
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 16.07%
2 Financials 9.42%
3 Healthcare 6.99%
4 Industrials 5.39%
5 Consumer Discretionary 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHTR icon
1176
Charter Communications
CHTR
$14.7B
$456K ﹤0.01%
1,235
-37
-3% -$13.2K
CLH icon
1177
Clean Harbors
CLH
$16.1B
$455K ﹤0.01%
2,295
+907
+65% +$198K
SNEX icon
1178
StoneX
SNEX
$8.83B
$455K ﹤0.01%
13,241
+5,360
+68% +$180K
CBRL icon
1179
Cracker Barrel
CBRL
$1.2B
$454K ﹤0.01%
11,342
+543
+5% +$27.4K
VDE icon
1180
Vanguard Energy ETF
VDE
$10.1B
$454K ﹤0.01%
3,533
-123
-3% -$15.5K
TNDM icon
1181
Tandem Diabetes Care
TNDM
$1.17B
$453K ﹤0.01%
23,142
+15,946
+222% +$467K
WTMF icon
1182
WisdomTree Managed Futures Strategy Fund
WTMF
$237M
$453K ﹤0.01%
13,187
-11,947
-48% -$416K
SYLD icon
1183
Cambria Shareholder Yield ETF
SYLD
$982M
$452K ﹤0.01%
7,111
+231
+3% +$15.6K
BIO icon
1184
Bio-Rad Laboratories Class A
BIO
$8.42B
$452K ﹤0.01%
1,860
+152
+9% +$45.7K
EELV icon
1185
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$427M
$452K ﹤0.01%
18,699
-20,036
-52% -$483K
TEVA icon
1186
Teva Pharmaceuticals
TEVA
$35.9B
$452K ﹤0.01%
30,114
-412
-1% -$7.36K
BAH icon
1187
Booz Allen Hamilton
BAH
$8.7B
$452K ﹤0.01%
4,400
-147
-3% -$17.7K
LRGF icon
1188
iShares US Equity Factor ETF
LRGF
$3.52B
$451K ﹤0.01%
7,845
+682
+10% +$41.6K
NUMG icon
1189
Nuveen ESG Mid-Cap Growth ETF
NUMG
$343M
$451K ﹤0.01%
10,518
+767
+8% +$35.8K
VTR icon
1190
Ventas
VTR
$48.9B
$451K ﹤0.01%
6,555
+74
+1% +$4.72K
JBBB icon
1191
Janus Henderson B-BBB CLO ETF
JBBB
$1.4B
$450K ﹤0.01%
9,220
+413
+5% +$20.3K
UGI icon
1192
UGI
UGI
$8B
$449K ﹤0.01%
13,672
+636
+5% +$20.1K
EPRT icon
1193
Essential Properties Realty Trust
EPRT
$6.99B
$449K ﹤0.01%
13,785
+202
+1% +$6.41K
BBVA icon
1194
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$447K ﹤0.01%
32,553
-239
-0.7% -$2.97K
XMMO icon
1195
Invesco S&P MidCap Momentum ETF
XMMO
$7.39B
$446K ﹤0.01%
3,944
+643
+19% +$79.2K
FXH icon
1196
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
$445K ﹤0.01%
4,316
-65
-1% -$6.96K
UHAL.B icon
1197
U-Haul Holding Co Series N
UHAL.B
$12.2B
$445K ﹤0.01%
7,551
+1,610
+27% +$101K
AXTA icon
1198
Axalta
AXTA
$7.01B
$445K ﹤0.01%
13,424
+2,302
+21% +$81.8K
FLXR
1199
TCW Flexible Income ETF
FLXR
$3.4B
$442K ﹤0.01%
11,286
+5,302
+89% +$206K
BALL icon
1200
Ball Corp
BALL
$17B
$441K ﹤0.01%
8,545
+3,157
+59% +$166K

Similar funds

&Partners's Q1 2025 Portfolio in Review

As of Q1 2025, &Partners held 1,822 positions worth $9.41B, up 13% from $8.34B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

&Partners deployed $1.36B of net new capital in Q1 2025, opening 181 new positions and adding to 1,122 existing holdings. Its largest new stake was First Trust Core Investment Grade ETF: 605,827 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was First Trust Smith Opportunistic Fixed Income ETF, an estimated $7.71M trimmed.

  • &Partners's largest Q1 2025 buy was First Trust Core Investment Grade ETF: 605,827 shares worth $15M.
  • &Partners added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $88.2M increase.
  • &Partners's biggest Q1 2025 reduction was First Trust Smith Opportunistic Fixed Income ETF, cutting an estimated $7.71M.
  • &Partners fully exited Aspen Technology Inc in Q1 2025, selling an estimated $3.18M.
  • &Partners's ten largest holdings make up 23% of its $9.41B portfolio in Q1 2025.
  • &Partners opened 181 new positions and closed 69 in Q1 2025.
  • &Partners's portfolio value rose 13% quarter-over-quarter to $9.41B.

Based on &Partners's 13F filing for Q1 2025, filed 15 May 2025.